| 52.73 |  -0.21 / -0.40% |
Data as of 4:02pm ET | Day’s Change |
| 52.76 |  +0.03 / +0.06% |
Volume: 19.4K |
| Impax Launches Generic Zomig - Analyst Blog 6:16pm / Zacks.com | Elan Provides Strategic Update - Analyst Blog May 21 / Zacks.com |
| Data on UCB's Neupro - Analyst Blog May 22 / Zacks.com | GlaxoSmithKline Stock Hits New 52-Week High (GSK) May 21 / TheStreet.com |
| XenoPort Resumes Horizant Supply - Analyst Blog May 22 / Zacks.com | Dirty Medicine May 15 / Fortune |
| Toll Reports Better-than-Expected Earnings: Ahead of the Ticker May 22 / TheStreet.com | Elan in Royalty Deal with THRX - Analyst Blog May 14 / Zacks.com |
| XenoPort Candidate Disappoints - Analyst Blog May 21 / Zacks.com | Wider-than-Expected Loss at ChemoCentryx - Analyst Blog May 14 / Zacks.com |
| Previous close | 52.94 |
| Today’s open | 52.58 |
| Day’s range | 52.30 - 52.86 |
| Volume | 1,438,175 |
| Average volume (3 months) | 2,757,814 |
| Market cap | $130.4B |
| Dividend yield | 4.45% |
| Earnings growth (last year) | -12.13% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +8.13% |
| Revenue growth (last year) | -4.52% |
| P/E ratio | -- |
| Price/Sales | 2.54 |
| Price/Book | 13.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck & Co Inc | +0.62 | +1.33% |
| SNYSanofi SA | -0.49 | -0.89% |
| NVSNovartis AG | -0.80 | -1.07% |
| BMYBristol-Myers Squibb... | +0.60 | +1.29% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.84 |
| Annual revenue (last year) | $42.1B |
| Annual profit (last year) | $7.3B |
| Net profit margin | 17.27% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Andrew Philip Witty |
Chief Financial Officer & Executive Director Simon Dingemans |
Corporate headquarters Brentford, Greater London |
.
